Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition

PHASE2CompletedINTERVENTIONAL
Enrollment

264

Participants

Timeline

Start Date

June 3, 2019

Primary Completion Date

June 26, 2020

Study Completion Date

June 26, 2020

Conditions
Chronic Kidney DiseasesInflammation
Interventions
BIOLOGICAL

Ziltivekimab

human IgG1k anti-human IL-6 monoclonal antibody

Trial Locations (49)

10461

Novo Nordisk Investigational Site, The Bronx

11021

Novo Nordisk Investigational Site, Great Neck

11768

Novo Nordisk Investigational Site, Northport

18104

Novo Nordisk Investigational Site, Allentown

20110

Novo Nordisk Investigational Site, Manassas

20770

Novo Nordisk Investigational Site, Greenbelt

25241

Novo Nordisk Investigational Site, Danville

28207

Novo Nordisk Investigational Site, Charlotte

28277

Novo Nordisk Investigational Site, Charlotte

28401

Novo Nordisk Investigational Site, Wilmington

28472

Novo Nordisk Investigational Site, Whiteville

28801

Novo Nordisk Investigational Site, Asheville

29651

Novo Nordisk Investigational Site, Greer

29707

Novo Nordisk Investigational Site, Fort Mill

30901

Novo Nordisk Investigational Site, Augusta

31904

Novo Nordisk Investigational Site, Columbus

32789

Novo Nordisk Investigational Site, Winter Park

33169

Novo Nordisk Investigational Site, Miami

34474

Novo Nordisk Investigational Site, Ocala

35205

Novo Nordisk Investigational Site, Birmingham

37205

Novo Nordisk Investigational Site, Nashville

37923

Novo Nordisk Investigational Site, Knoxville

44224

Novo Nordisk Investigational Site, Stow

48066

Novo Nordisk Investigational Site, Roseville

48081

Novo Nordisk Investigational Site, Saint Clair Shores

48202

Novo Nordisk Investigational Site, Detroit

48723

Novo Nordisk Investigational Site, Caro

52242

Novo Nordisk Investigational Site, Iowa City

53142

Novo Nordisk Investigational Site, Kenosha

55404

Novo Nordisk Investigational Site, Minneapolis

60643

Novo Nordisk Investigational Site, Chicago

71201

Novo Nordisk Investigational Site, Monroe

75246

Novo Nordisk Investigational Site, Dallas

76180

Novo Nordisk Investigational Site, North Richland Hills

77017

Novo Nordisk Investigational Site, Houston

77043

Novo Nordisk Investigational Site, Houston

77070

Novo Nordisk Investigational Site, Houston

78212

Novo Nordisk Investigational Site, San Antonio

78229

Novo Nordisk Investigational Site, San Antonio

80002

Novo Nordisk Investigational Site, Arvada

85016

Novo Nordisk Investigational Site, Phoenix

85018

Novo Nordisk Investigational Site, Phoenix

85210

Novo Nordisk Investigational Site, Mesa

90262

Novo Nordisk Investigational Site, Lynwood

91773

Novo Nordisk Investigational Site, San Dimas

92503

Novo Nordisk Investigational Site, Riverside

92505

Novo Nordisk Investigational Site, Riverside

02903

Novo Nordisk Investigational Site, Providence

05401

Novo Nordisk Investigational Site, Burlington

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY